Dear HMS-CSSA members,

It is our great honor to announce that Dr. Jiping Wang has recently agreed to join the advisor board of HMS-CSSA (Attached is the bio-sketch of Dr. Wang). Dr. Wang is Assistant Professor, Harvard Medical School, Associate Director of Hepatobilliary Cancer Program, Division of Surgical Oncologyat Brigham and Women’s Hospital. With his support, we believe HMS-CSSA will be able to serve our community better.

We are looking forward to working with him in the future.

Best

HMS-CSSA

Bio-sketch of Dr. Wang:

Jiping Wang, MD, PhD
Assistant Professor, Harvard Medical School
Associate Director of Hepatobilliary Cancer Program, Division of Surgical Oncology at Brigham and Women’s Hospital

Dr. Wang received his PhD training in Biostatistics at University of Pittsburgh. He served as a biostatistician at National Surgical Adjuvant Breast and Bowel Project, where he participated in multiple phase III breast cancer clinical trials upon his graduation. During Dr. Wang’s surgical residency training at the State University of New York at Buffalo, he was appointed as an adjunct assistant professor in the Department of Biostatistics and a statistical consultant at Roswell Park Cancer Institute. He developed a unique statistical course for residents and fellows named “Anatomy of Biostatistics”. Subsequently, Dr. Wang obtained the Fineberg Fellowship to train at Brigham and Women’s Hospital, Massachusetts General Hospital and Dana Farber Cancer Institute.
Dr. Wang practices oncologic surgery with a focus on minimally-invasive cancer surgery for gastrointestinal malignancies including liver cancer, colorectal cancer, liver metastasis, pancreatic, gastric, colorectal cancer and neuroendocrine tumors.

Dr. Wang’s research focuses on identification of tumor markers for cancer screening, monitoring treatment effectiveness and prognosis; development of algorithms and/or scoring systems to guide clinical oncology research and practice, and clinical trials for cancer prevention and treatment. Dr. Wang has been involved in clinical research on breast and GI cancer for over 10 years. His research in oncology has received many national level awards including: ASCO Annual Meeting Merit Award (2008, 2010), ASCO Breast Cancer Symposium Merit Award (2007), Seed Grant from American Medical Association Foundation (2008) and AstraZeneca Scholar (2002). He also won the Leadership Scholarship from American College of Surgeons (ACS) 2008 and the scholarship from ASCO/AACR (2009). Dr. Wang serves as a committee member for multiple surgical societies including American College of Surgeons and Society for Surgery of Alimentary Tract.